These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18445772)

  • 1. Forced expression of MMP9 rescues the loss of angiogenesis and abrogates metastasis of pancreatic tumors triggered by the absence of host SPARC.
    Arnold S; Mira E; Muneer S; Korpanty G; Beck AW; Holloway SE; Mañes S; Brekken RA
    Exp Biol Med (Maywood); 2008 Jul; 233(7):860-73. PubMed ID: 18445772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis.
    Puolakkainen PA; Brekken RA; Muneer S; Sage EH
    Mol Cancer Res; 2004 Apr; 2(4):215-24. PubMed ID: 15140943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma.
    Arnold SA; Rivera LB; Miller AF; Carbon JG; Dineen SP; Xie Y; Castrillon DH; Sage EH; Puolakkainen P; Bradshaw AD; Brekken RA
    Dis Model Mech; 2010; 3(1-2):57-72. PubMed ID: 20007485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation.
    Arnold SA; Rivera LB; Carbon JG; Toombs JE; Chang CL; Bradshaw AD; Brekken RA
    PLoS One; 2012; 7(2):e31384. PubMed ID: 22348081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced angiogenesis characteristic of SPARC-null mice disappears with age.
    Reed MJ; Bradshaw AD; Shaw M; Sadoun E; Han N; Ferara N; Funk S; Puolakkainen P; Sage EH
    J Cell Physiol; 2005 Sep; 204(3):800-7. PubMed ID: 15795937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM.
    Brekken RA; Puolakkainen P; Graves DC; Workman G; Lubkin SR; Sage EH
    J Clin Invest; 2003 Feb; 111(4):487-95. PubMed ID: 12588887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions.
    Sato N; Fukushima N; Maehara N; Matsubayashi H; Koopmann J; Su GH; Hruban RH; Goggins M
    Oncogene; 2003 Aug; 22(32):5021-30. PubMed ID: 12902985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyses of the role of endogenous SPARC in mouse models of prostate and breast cancer.
    Wong SY; Crowley D; Bronson RT; Hynes RO
    Clin Exp Metastasis; 2008; 25(2):109-18. PubMed ID: 18058030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA.
    Kunigal S; Gondi CS; Gujrati M; Lakka SS; Dinh DH; Olivero WC; Rao JS
    Int J Oncol; 2006 Dec; 29(6):1349-57. PubMed ID: 17088972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPARC suppresses lymph node metastasis by regulating the expression of VEGFs in ovarian carcinoma.
    Peng F; Zhong Y; Liu Y; Zhang Y; Xie Y; Lu Y; Zhang X; Li D
    Int J Oncol; 2017 Dec; 51(6):1920-1928. PubMed ID: 29075785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory macrophages activate invasion in pancreatic adenocarcinoma by increasing the MMP9 and ADAM8 expression.
    Puolakkainen P; Koski A; Vainionpää S; Shen Z; Repo H; Kemppainen E; Mustonen H; Seppänen H
    Med Oncol; 2014 Mar; 31(3):884. PubMed ID: 24526468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPARC expression is negatively correlated with clinicopathological factors of gastric cancer and inhibits malignancy of gastric cancer cells.
    Zhang J; Wang P; Zhu J; Wang W; Yin J; Zhang C; Chen Z; Sun L; Wan Y; Wang X; Chen G; Liu Y
    Oncol Rep; 2014 May; 31(5):2312-20. PubMed ID: 24676680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic stellate cells derived from human pancreatic cancer demonstrate aberrant SPARC-dependent ECM remodeling in 3D engineered fibrotic tissue of clinically relevant thickness.
    Tanaka HY; Kitahara K; Sasaki N; Nakao N; Sato K; Narita H; Shimoda H; Matsusaki M; Nishihara H; Masamune A; Kano MR
    Biomaterials; 2019 Feb; 192():355-367. PubMed ID: 30476717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase D2 induces invasion of pancreatic cancer cells by regulating matrix metalloproteinases.
    Wille C; Köhler C; Armacki M; Jamali A; Gössele U; Pfizenmaier K; Seufferlein T; Eiseler T
    Mol Biol Cell; 2014 Feb; 25(3):324-36. PubMed ID: 24336522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An orthotopic model of lung cancer to analyze primary and metastatic NSCLC growth in integrin alpha1-null mice.
    Chen X; Su Y; Fingleton B; Acuff H; Matrisian LM; Zent R; Pozzi A
    Clin Exp Metastasis; 2005; 22(2):185-93. PubMed ID: 16086239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of SPARC in lens epithelial cells results in altered adhesion and extracellular matrix production in vitro.
    Weaver MS; Sage EH; Yan Q
    J Cell Biochem; 2006 Feb; 97(2):423-32. PubMed ID: 16211577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis.
    Sangaletti S; Di Carlo E; Gariboldi S; Miotti S; Cappetti B; Parenza M; Rumio C; Brekken RA; Chiodoni C; Colombo MP
    Cancer Res; 2008 Nov; 68(21):9050-9. PubMed ID: 18974151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix.
    Chlenski A; Liu S; Guerrero LJ; Yang Q; Tian Y; Salwen HR; Zage P; Cohn SL
    Int J Cancer; 2006 Jan; 118(2):310-6. PubMed ID: 16052522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I collagen-deficient Mov-13 mice do not retain SPARC in the extracellular matrix: implications for fibroblast function.
    Iruela-Arispe ML; Vernon RB; Wu H; Jaenisch R; Sage EH
    Dev Dyn; 1996 Oct; 207(2):171-83. PubMed ID: 8906420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPARC-null mice exhibit accelerated cutaneous wound closure.
    Bradshaw AD; Reed MJ; Sage EH
    J Histochem Cytochem; 2002 Jan; 50(1):1-10. PubMed ID: 11748289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.